• Source: Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency

3/info/long" target="_blank">Long-3/info/chain" target="_blank">chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency is a rare autosomal recessive fatty acid oxidation disorder that prevents the body from converting certain fats into energy. This can become life-threatening, particularly during periods of fasting.




Symptoms and signs


Typically, initial signs and symptoms of this disorder occur during infancy or early childhood and can include feeding difficulties, lethargy, hypoglycemia, hypotonia, liver problems, and abnormalities in the retina. Muscle pain, a breakdown of muscle tissue, and abnormalities in the nervous system that affect arms and legs (peripheral neuropathy) may occur later in childhood. There is also a risk for complications such as life-threatening heart and breathing problems, coma, and sudden unexpected death. Episodes of LCHAD deficiency can be triggered by periods of fasting or by illnesses such as viral infections.




Genetics


Mutations in the HADHA gene lead to inadequate levels of an enzyme called 3/info/long" target="_blank">long-3/info/chain" target="_blank">chain 3-hydroxyacyl-coenzyme A (CoA) dehydrogenase, which is part of a protein complex known as mitochondrial trifunctional protein. 3/info/long" target="_blank">Long-3/info/chain" target="_blank">chain fatty acids from food and body fat cannot be metabolized and processed without sufficient levels of this enzyme. As a result, these fatty acids are not converted to energy, which can lead to characteristic features of this disorder, such as lethargy and hypoglycemia. 3/info/long" target="_blank">Long-3/info/chain" target="_blank">chain fatty acids or partially metabolized fatty acids may build up in tissues and damage the liver, heart, retina, and muscles, causing more serious complications.




Diagnosis


Diagnoses are typically made based on newborn screening done from blood obtained using a heel prick at birth. Prior to widespread inclusion of FAO (fatty acid oxidation) disorders in newborn screening tests, diagnosis typically occurred as a result of children presenting for medical attention having hypoglycemic hypoketotic crisis.




Prognosis


A 2001 study followed up on 50 patients. Of these 38% died in childhood while the rest suffered from problems with morbidity. However, with certain dietary and lifestyle choices, it is possible for sufferers of LCHAD to live comfortable and happy lives.




See also


Medium 3/info/chain" target="_blank">chain acyl dehydrogenase deficiency




References






External links

Kata Kunci Pencarian:

• Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency
• HADHA
• Beta oxidation
• Acute fatty liver of pregnancy
• Inborn error of lipid metabolism
• Chromosome 2
• List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders
• Acyl-CoA
• Mitochondrial trifunctional protein
• Fatty-acid metabolism disorder